Seroconversion rate (after 2 primary doses) · children
Equivalent schedules of intradermal fractional‐dose inactivated… may leads to lower seroconversion rate (after 2 primary doses) compared with intramuscular inactivated poliovirus vaccine (low certainty).
1 finding from 1 review
Seroconversion rate (after 3 primary doses) · children
It is very uncertain whether equivalent schedules of intradermal fractional‐dose inactivated… changes seroconversion rate (after 3 primary doses) compared with intramuscular inactivated poliovirus vaccine (very low certainty).
1 finding from 1 review
Antibody response (geometric mean titre) · children
1 finding from 1 review
Vaccine‐related adverse events · children
1 finding from 1 review
Occurrence of new cases of colic Measured by: Wessel/Rome III Criteria · infants without colic
Prophylactic probiotics showed no clear difference in occurrence of new cases of colic Measured by: Wessel/Rome III Criteria compared with placebo (low certainty).
1 finding from 1 review
Adverse effects Measured by: reporting · infants without colic
Prophylactic probiotics showed no clear difference in adverse effects Measured by: reporting compared with placebo (low certainty).
1 finding from 1 review
Crying time at completion Measured in: minutes/day · infants without colic
1 finding from 1 review
Intervention not reported
Stunting · children aged 6 to 23 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Anaemia Measured as haemoglobin < 10 g/dL Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention may leads to lower anaemia Measured as haemoglobin < 10 g/dL Measured at 12, 18 and 24… (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects Defined as deaths, hospitalisations, congenital abnormalities and life‐threatening conditions requiring an immediate hospital visit Assessed at 12 and 18 months of age · children aged 6 to 23 months
The intervention showed no clear difference in adverse effects Defined as deaths, hospitalisations, congenital… (moderate certainty).
1 finding from 1 review
Intervention not reported
Stunting · children aged 6 to 23 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Severe stunting Measured as height‐for‐age z score < −3 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention showed no clear difference in severe stunting Measured as height‐for‐age z score < −3 SD Measured… (low certainty).
1 finding from 1 review
Intervention not reported
Wasting · children aged 6 to 23 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Moderate wasting Measured as weight‐for‐height z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate wasting Measured as weight‐for‐height z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Severe wasting Measured as weight‐for‐height z score < −3 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention showed no clear difference in severe wasting Measured as weight‐for‐height z score < −3 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Underweight · children aged 6 to 23 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Moderate underweight Measured as weight‐for‐age z score < −2 SD Measured at 12 months and 18 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate underweight Measured as weight‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate stunting Measured as height‐for‐age z score < −2 SD Measured at 12, 18 and 24 months of age · children aged 6 to 23 months
The intervention probably leads to lower moderate stunting Measured as height‐for‐age z score < −2 SD… (moderate certainty).
1 finding from 1 review
Intervention not reported
Severe underweight Measured as weight‐for‐age z score < −3 SD Measured at 12 months of age · children aged 6 to 23 months
The intervention showed no clear difference in severe underweight Measured as weight‐for‐age z score < −3 SD… (low certainty).
1 finding from 1 review